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Os neurónios são um tipo celular altamente especializado e em condições 
fisiológicas normais a transmissão sináptica está envolvida em processos homeostáticos 
essenciais, nomeadamente em fenómenos de aprendizagem e memória. No entanto, 
durante um episódio isquémico os níveis de ATP decrescem para níveis abaixo do limiar 
necessário para os neurónios manterem os seus gradientes iónicos. Como resultado, o 
neurotransmissor glutamato é massivamente libertado e acumulado no espaço 
extracelular. O excessivo influxo de Ca2+ para a célula pós-sináptica devido à 
sobreactivação dos receptores do glutamato é responsável por iniciar diversas cascadas 
responsáveis por induzir morte celular. 
 Em condições fisiológicas normais o sistema ubiquitina-proteossoma (UPS) é 
responsável pela reciclagem de numerosas proteínas, assim como pela degradação de 
proteínas danificadas. O UPS é o principal sistema de proteólise intracelular em células 
eucarióticas. Antes de as proteínas serem degradadas no UPS são primeiro marcadas com 
quatro (ou mais) ubiquitinas, por acção de ligases de ubiquitina (E3), sendo 
posteriormente enviadas para degradação no proteossoma 26S, um grande complexo 
dependente de energia composto por uma subunidade reguladora (19S) e por uma 
subunidade catalítica (20S). Tem sido demonstrado em diversos modelos de isquémia 
transiente global que o proteossoma 26S é desmontado nas suas subunidades 
constituintes, 19S e 20S, sugerindo o seu comprometimento após isquemia.  
Tendo em conta o papel desempenhado pela activação excessiva dos receptores do 
glutamato na morte neuronal na isquemia cerebral, neste trabalho foi estudado o efeito da 
excitotoxicidade na actividade do proteossoma em culturas de neurónios do hipocampo. 
Verificou-se uma redução transitória da actividade de quimiotripsina do 
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proteossoma, em cerca de 50%, 4 h após uma breve estimulação com glutamato (125 
μM, 20min), tendo-se observado uma redução da viabilidade celular nas mesmas 
condições experimentais. A inibição do proteossoma em neurónios do hipocampo 
submetidos a condições de excitotoxicidade foi confirmada usando um repórter de 
actividade do proteossoma UbG76V-GFP. Foi observada um aumento de cerca de 2.67 
vezes na acumulação de UbG76V-GFP em neurónios expostos a condições de 
excitotoxicidade quando comparado com o controlo. Ao contrário do estímulo 
excitotóxico que reduziu a actividade do proteossoma e induziu morte celular num 
período de 4 h após a lesão, a incubação dos neurónios do hipocampo com o inibidor do 
proteossoma MG132 durante 5 h não teve qualquer efeito sobre a viabilidade celular. Só 
foi observada morte celular em resposta a incubações prolongadas (superiores a 8 h) 
com 0.05 µM e 1 µM do inibidor do proteossoma β-lactona. Estes resultados sugerem 
que a inibição do proteossoma não desempenha um papel relevante na morte neuronal 
em condições de excitotoxicidade. 
Neste trabalho estabelecemos ainda um protocolo para OGD em culturas de 
neurónios corticais. Foi observado um aumento da morte celular em cerca de 13,8% 
após um período de OGD de 2 h, seguido da incubação em meio de cultura 
condicionado, durante 12 h. Demonstrámos ainda a formação rápida de produtos de 
clivagem da proteína do citoesqueleto α-espectrina, com 145 e 150 kDa, 30min após o 
estímulo de OGD. A formação destes fragmentos sugere que as calpaínas são activadas 
rapidamente após a lesão isquémica in vitro.  
No conjunto, estes resultados sugerem que em condições excitotóxicas, 
características da isquemia cerebral por exemplo, ocorrem alterações bioquímicas que 
levam à desregulação do proteossoma e que, durante OGD há clivagem de proteínas do 
citoesqueleto que sugerem uma activação rápida das calpaínas. A prevenção de todas 
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estas alterações bioquímicas pode ser encarada com uma potencial estratégia 
neuroprotectora que valerá a pena ser explorada. 
 
Palavras-chave: OGD; excitotoxicidade; receptores do glutamato; ubiquitina; 
proteossoma 
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Neurons are a very specialized cell type and proper synaptic transmission is 
involved in several important homeostatic mechanisms such as learning and memory. 
However, during an ischemic episode, ATP levels drop below the threshold required for 
normal cellular activity and ion gradients are dissipated. As a result, the 
neurotransmitter glutamate is massively released and accumulated in the extracellular 
space, and the excessive activation of glutamate receptors induces a Ca2+ overload into 
postsynaptic neurons which initiate cell death cascades. 
Under normal physiological conditions the ubiquitin-proteasome system (UPS) 
is responsible for the turn-over of proteins and for the degradation of damaged proteins. 
The UPS is the major proteolytic system in eukaryotic cells, and before degradation the 
substrate proteins are first tagged with four (or more) ubiquitin molecules by E3 ligases. 
Ubiquitinated proteins are then delivered to the 26S proteasome, a large energy-
dependent entity consisting of a 20S catalytic core and a 19S regulatory particle, where 
they are degraded. The 26S proteasome was shown to be disassembled into the 20S and 
19S particle in several models of brain ischemia, suggesting that is may be impaired.  
Given the role of excessive activation of glutamate receptors in neuronal death 
in brain ischemia, we investigated the effect of excitotoxicity on the proteasome activity 
in cultured hippocampal neurons. The chymotrypsin-like activity of the proteasome 
decreased by 50% when determined 4 h after excitotoxic stimulation with glutamate 
(125 µM glutamate; 20 min), and these results were correlated with a decrease in cell 
survival. Inhibition of the proteasome following excitotoxic stimulation with glutamate 
was confirmed by using the proteasome activity reporter UbG76-GFP, which showed an 
increased accumulation (2.67 fold) in hippocampal neurons exposed to glutamate when 
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compared with the control. In contrast with the effect of excitotoxic stimulation which 
decreased proteasome activity and induced cell death within 4 h after the insult, 
incubation of hippocampal neurons with the proteasome inhibitor MG132 for 5 h did 
not affect cell viability. Proteasome inhibition with 0.05 and 1 µM β-lactone was 
induced hippocampal cell death only after incubation for more than 8 h. These results 
suggest that proteasome inhibition is not the major effector in excitotoxic neuronal 
death. 
We have also established a new OGD protocol to use in cultured cortical 
neurons. Exposure of cortical neurons to OGD for 2 h followed by incubation in culture 
conditioned medium for 12 h increased cell death by 13.8% when compared to the 
control. Cleavage of the cytoskeletal protein α-spectrin into its major 150 kDa and 145 
kDa breakdown products was an early event after OGD, being observed at 30 min after 
the insult. The formation of these α-spectrin cleavage products suggests that calpains are 
rapidly activated under the experimental conditions used in this work. 
Taken together, the results suggest that excitotoxic glutamate application 
induces biochemical changes in the proteasome resulting in its downregulation, and 
OGD induces breakdown of cytoskeleton proteins prompting its disorganization. 
Preventing these biochemical changes can be a potential neuroprotective strategy to be 
exploited. 
 
Key words: OGD; excitotoxicity; glutamate receptors; ubiquitin; proteasome 
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1.1- The Glutamatergic Synapse 
Glutamate, the major excitatory neurotransmitter in the central nervous system 
(CNS), acts on synaptic transmission primarily through activation of ionotropic and 
metabotropic glutamate receptors present in the postsynaptic membrane. Excitatory 
synapses are characterized by the presence of an electro-dense ~30-40 nm thick 
structure in the postsynaptic site, termed the postsynaptic density (PSD) (Figure 1). This 
large structure is build-up of several membrane-bound receptors, cytoskeleton and 
scaffold proteins and also signaling molecules. Numerous scaffolding proteins have 
been described such as the postsynaptic density protein 95 (PSD-95), guanylate-kinase 
associated proteins (GKAP) and Shank protein family members. Signaling molecules 
such as Ca2+/calmodulin-dependent protein kinase (CaMKII) and neuronal nitric oxide 
synthase (nNOS) are also present in the PSD (Figure 2) (Sheng et al., 2007). 
 
 
Figure 1- Electron microscopy photograph of an excitatory synapse. The presynaptic 
terminal contains synaptic vesicles loaded with glutamate, facing the postsynaptic density 
(PSD) located on the tip of the dendritic spine (adapted from Kaeser et al., 2011). 
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Three classes of ionotropic glutamate receptors (iGluR) have been described, the 
N-methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid 
(AMPA) and kainate (KA) receptors (Figure 2). Activation of these receptors with 
glutamate increases the permeability to Na+ and some of the iGluR are also Ca2+ 
permeable. Unlike the ionotropic receptors, the metabotropic receptors (mGluRs) are G-
protein coupled receptors and act intracellularly by elevating several second messengers 
such as inositol-1,4,5-triphosphate (IP3), Ca
2+, diacylglicerol (DAG) (group I mGluRs) or 
decreasing the cyclic adenosine monophosphate (cAMP) (groups II and III mGluRs) 
(Niciu et al., 2012).  
NMDA receptors (NMDARs) are composed of four subunits, two obligatory 
GluN1 subunits, which contain the binding sites for the co-agonist glycine (or D-serine), 
and two GluN2 subunits (GluN2A-D), responsible to bind glutamate. In addition, 
NMDARs can also have in its composition GluN3A-B subunits. Under non-excitable 
conditions the NMDAR channel pore is blocked by Mg2+ (Lau et al., 2010). In contrast, 
AMPA receptors (AMPARs) are made up of four subunits (GluA1-4) and mediate fast 
excitatory neurotransmission in the CNS. While the GluA1, 3 and 4 subunits are 
permeable to Ca2+, GluA2-containing AMPARs are generally Ca2+ impermeable. 
AMPARs activation by glutamate depolarizes the post-synaptic neuron due to the influx 
of Na+, removing the Mg2+ ion blockade from NMDAR channels and allowing the influx 
of Ca2+ (Santos et al., 2009; Niciu et al., 2012). The NMDARs can be found in synaptic 
sites (adjacent to the presynaptic terminal) or in extrasynaptic sites. While synaptic 
receptors are associated with neuronal survival, neuroprotection and with the molecular 
mechanism of learning and memory, such as LTP (long-term potentiation) and LTD 
(long-term depression), the NMDA receptors located in extrasynaptic sites are often 
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associated with cell death mechanisms (Hardingham et al., 2002; Hardingham et al., 
2010).  
The glutamate released from the nerve terminal is then taken up mainly by 
astrocytes, thereby preventing an excessive activation of its receptors present at the 
synapse. Extracellular glutamate is cleared by the action of excitatory amino acid 
transporters (EEAT1-5). In the CNS, both neurons and glial cells express the EEAT2 
subtype, the most abundant form of these transporters. Glutamate is co-transported with 
three Na+ and one H+, and the counter transport of one K+ and one OH- (Chao et al., 2010; 
Niciu et al., 2012). 
 
Figure 2- Overview of the glutamatergic synapse. Upon an action potential arrival in the 
pre-synaptic terminal, glutamate containing synaptic vesicle are release to the synaptic cleft. 
Under physiological conditions, glutamate acts on ionotropic (NMDA, AMPA and KA 
receptors) or metabotropic glutamate receptors (not shown) located at the synapse. Glutamate 
present in the synaptic cleft is uptaken mainly by glial cells and then converted to glutamine by 
the glutamine synthetase. Glutamine can be further converted to glutamate in the presynaptic 
neurons by glutaminase and stored in synaptic vesicles (glutamine-glutamate cycle). All the 
synaptic components are embedded in a network of scaffolding proteins essential to maintain 
proper neurotransmission. 
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1.2- Brain Ischemia 
 Due to its high energy demand, the brain is the major oxygen consuming organ in 
the entire human body. This oxygen is used to generate adenosine triphosphate (ATP) and 
a proper blood flow is thus crucial also to provide glucose, amino acids and other trophic 
factors. Consequently, it is highly conceivable that an interruption of the blood flow in the 
brain (from hereafter stroke) can be very deleterious to the tissue. After focal ischemia, 
ATP levels drop abruptly and cell death occurs very rapidly in the central part that is 
deprived from blood supply (ischemic core). However, in the vicinity, where collateral 
blood flow is not fully restricted (ischemic penumbra), neuronal damage is often less 
severe and this region can be potentially salvageable (Iadecola et al., 2011; Hossmann et 
al., 2012). 
Stroke can be subdivided in two major categories: ischemic or hemorrhagic. 
Ischemic strokes (Figure 3A) are the most prevalent ones, making up approximately 87% 
of all cases and are the result of an obstruction within a blood vessel supplying blood to 
the brain. The hemorrhagic stroke (Figure 3B) takes account of 13 % of all cases and 
results from a weakened vessel that ruptures and bleeds into the surrounding brain. A 
third type of stroke, transient ischemic attack (TIA), has also been suggested. The TIA 
(Figure 3C) is a mini-stroke caused by a clot that can dissolve by itself with a question of 
minutes, and is the so called “warning stroke” (Doyle et al., 2008; 
http://www.strokeassociation.org). 
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Figure 3- Types of stroke. A) In the ischemic stroke, the vessel is blocked by a clot stopping 
the blood flow to the surrounding tissue; B) In the hemorrhagic stroke, the vessel cannot cope 
with the high pressure of the blood and eventually collapse; C) The transient ischemic attack is 
a less severe type of stroke when compared with the ischemic stroke. The size of the clot is 
smaller and therefore blocks transiently the blood vessel (adapted form 
www.strokeassociation.org). 
1.3- Excitotoxicity 
1.3.1- Role of Glutamate in excitotoxicity 
The term excitotoxicity was first coined in the 60´s by John Olney. He discovered 
that when applied at higher concentrations, excitatory neurotransmitters such as glutamate 
induce neuronal death (Olney et al., 1969). Excitotoxicity is a common feature in several 
disorders of the nervous system, including stroke, traumatic brain injury (TBI), epilepsy 
and in neurodegenerative disorders (Lau et al., 2010). 
 Neuronal deprivation both from glucose and oxygen causes a reduction in ATP. 
Consequently, the Na+ and K+ gradient is lost due the failure of the Na+/K+ ATPase, 
which is responsible to maintaining higher concentrations of Na+ and K+ outside and 
inside the cell, respectively. Thus, neurons become highly depolarized and glutamate is 
massively released by the Ca2+-dependent exocytotic mechanism (Grewer et al., 2008). 
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However, glutamate can also be released by a Ca2+-independent mechanism mediated by 
reversal of the EAAT in response to alterations in the electrochemical Na+ gradient. This 
is the case under conditions of energy deprivation, which favor the release of glutamate 
and do not allow the uptake of extracellular glutamate (Grewer et al., 2008). The 
depletion of extracellular divalent ions such as Ca2+, Mg2+ and others, due to ionic 
unbalance, also promotes the release of glutamate through astrocytic hemichannels (Ye et 
al., 2003). 
1.3.2- Role of Ca2+ in excitotoxicity 
 One of the first studies showing that an intracellular calcium overload may play a 
role in neuronal death was published by Dennis Choi back in the late 80´s. He found that 
glutamate excitotoxicity depends on two temporal components. The first component, the 
acute one, induces neuronal disintegration and is dependent of extracellular Na+, while 
the second, occurring at a late phase, is Ca2+-dependent (Choi et al., 1987). Further 
studies have shown that upon oxygen and glucose deprivation, glutamate is massively 
released by neurons, thereby increasing the intracellular Ca2+ concentration ([Ca2+]i) 
(Goldberg et al., 1993). Ca2+ uptake and neuronal cell death were prevented by the 
NMDAR antagonist D-aminophosphonovalerate (APV), indicating that NMDARs are the 
link between glutamate, Ca2+ and cell death (Goldberg et al., 1993). However, this rise in 
[Ca2+]i is not permanent, and neurons are able to buffer their [Ca
2+]i. Thus, after 
stimulation of hippocampal neurons with 500 µM glutamate for 5 min there is a rapid 
increase in the [Ca2+]i by ~2.5 fold, which then returns to basal levels 20 min after 
stimulation (Dubinsky et al., 1993). Studies performed in a similar model showed three 
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different phases of [Ca2+]i overload following stimulation of cultured hippocampal 
neurons with 100 µM glutamate for 5 min. An initial phase, lasting from 5 to 10 min, was 
followed by a decrease to basal levels during a 2 h period and a final increase in the 
[Ca2+]i was often associated with increased cell death (Randall et al., 1992). There are 
additional routes for Ca2+ entry, besides the activation of ionotropic glutamate receptors 
(excitotoxic mechanisms), which may also contribute to the neuronal damage. Transient 
receptor potential melastatin (TRPM) channels, volume-regulated anion channels 
(VRAC), acid-sensing ion channels (ASICs; sensitive to the cytosolic pH acidification 
during excitotoxic glutamate application), voltage-gated calcium channels (VGCC) and 
others, have all been proposed to mediate Ca2+ influx (non-excitotoxic mechanisms) 
under excitotoxic conditions (Hartley et al., 1993; Besancon et al., 2008; Stanika et al., 
2012). 
 Ca2+ overload can also contribute to the formation of free radicals due to a 
persistent mitochondrial depolarization, leading to a depletion of anti-oxidant defenses 
and a consequent accumulation of reactive oxygen species (ROS) (Schubert et al., 2001). 
Moreover, upon brain ischemia there is an increased interaction between cytosolic 
neuronal nitric oxide synthetase (nNOS) and the post-synaptic protein PSD-95. The 
formation of the complex nNOS-PSD-95 upregulates the production of nitric oxide (NO), 
which gives rise to peroxynitrite, another potent oxidant agent that is capable of causing 
protein nitration, protein oxidation, lipid peroxidation and direct DNA damage (Lau et al., 
2010; Zhou et al., 2010). Furthermore, the [Ca2+]i overload induces several potentially 
harmful cascades, which contribute to cell death, including activation of ATPases, 
lipases, DNAases and proteases (Figure 4) (Besancon et al., 2008). 
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Figure 4- Mechanisms activated by Ca2+ ionic unbalance. During an ischemic episode, ATP 
depletion leads to a massive Ca2+ influx in the post-synaptic cell. Abnormal [Ca2+]i can activate 
a wide range of cell death executioners such as ATPases, lipases, proteases and DNAses 
(Besancon et al., 2008). 
1.4- Proteases and excitotoxicity 
1.4.1- Calpains 
Calpains belong to the family of calcium-regulated cysteine proteases and the best 
characterized brain calpains are the isoforms µ- and m-calpain. Activation of µ-calpain 
requires ~100 fold less Ca2+ when compared to the m-calpain, and several studies have 
shown a role for calpain activation in cell death induced by excitotoxic insults (Bevers et 
al., 2008). Studies performed in transgenic mice overexpressing human calpastatin 
(hCAST), an endogenous inhibitor of µ- and m-calpain, showed a decrease in kainate-
induced excitotoxic cell death in the CA1 region of the hippocampus when compared 
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with wild type mice. This was mainly attributed to the maintenance of the integrity of 
cytoskeleton organization when compared with non-trangenic mice (Higuchi et al., 2005). 
Moreover, calpain inhibition due to calpastatin overexpression in these mutant mice was 
found to suppress the nuclear translocation of the apoptosis-inducing factor (AIF) and 
endonuclease G, which induce DNA fragmentation and promote cell death (Takano et al., 
2005). 
Several important proteins involved in the [Ca2+]i homeostasis are also cleaved by 
calpains, contributing to the triphasic regulation of [Ca2+]i following the excitotoxic 
insult. While the first increase in Ca2+ is directly arises from the activation of NMDA 
receptors (excitotoxic mechanism), the second increase is mainly due to the inability to 
extrude Ca2+ (non-excitotoxic mechanism) (Figure 5). The Na+/Ca2+ exchanger (NCX) 
and the plasma membrane Ca2+ATPase (PMCA) are the best characterized calpain 
substrates, and their truncation prevents the cell from extruding Ca2+, thereby contributing 
to neuronal cell death (Bevers et al., 2008). On the other hand, calpains also generate an 
active proteolytic fragment of the proapoptotic Bcl-2 family member Bid, and the 
truncated protein (tBid) induces cytochrome-c and AIF release from the mitochondria, 
initiating an apoptotic signaling cascade by caspase-dependent and caspase-independent 
mechanisms, respectively (Takano et al., 2005). 
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Figure 5- Routes for Ca2+ entry during excitotoxic and non-excitotoxic conditions. Several 
mechanisms can contribute to the [Ca2+]i overload during an excitotoxic episode. Ca
2+ enters 
primarily through NMDA receptors, and secondary waves can be generated due to the 
activation of the transitory receptor potential melastatin (TRPM) ion channels and acid-sensing 
ion channels (ASICs). Activation of calpains during excessive Ca2+ influx can contribute to the 
cleavage of Ca2+-extruding pumps, such as the Na+/Ca2+ exchanger (NCX3) and plasma 
membrane Ca2+-ATPase (PMCA) (Bano et al., 2007). 
1.4.2- Caspases 
Caspases are cysteine proteases that cleave the substrates after aspartic residues 
and are responsible for the control of cell death and differentiation processes (Wang et al., 
2000). They can be further subdivided in initiator (caspase 2, 8, 9, and 10) and effector 
caspases (caspase 3, 6, and 7). The effector caspases are activated through controlled 
proteolysis by the initiator caspases. Caspase-3 is a key player in regulating cell death 
(Zille et al., 2012), sharing common substrates with calpains, namely α-spectrin, 
calpastatin and CaMKII (Wang et al., 2000). 
Excitotoxic stimulation of cultured hippocampal neurons with glutamate (15 min 
stimulation) was shown to induce apoptotic-like cells death when determined 7 h after the 
insult (Almeida et al., 2005). In addition, active (cleaved) caspase-3 was increased by ~4-
fold 5 h after the insult, when compared with non-stimulated neurons. Although the time 
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window between activation of caspase-3 and initiation of cell death was not investigated 
in this work, caspase inhibitors such as zVAD-fmk and zDEVD-fmk, a pan-caspase 
inhibitor and a caspase-3 inhibitor, respectively, were shown to protect hippocampal 
neurons subjected to excitotoxic stimulation (Glazner et al., 2000; Almeida et al., 2005). 
Moreover, in vivo studies performed in rats subjected to 5 min of transient forebrain 
ischemia showed an accumulation of the p53 protein in the mitochondrial fraction after 8 
h of reperfusion, and this translocation activates the initiator caspase-9 (Endo et al., 
2006). These data suggest that caspases play an important role in cell death (directly or 
indirectly) under excitotoxic condition and the use of caspase inhibitors can be a potential 
therapeutic target to prevent cell death during brain ischemia. 
1.5- Neuroprotective strategies 
Since overactivation of NMDARs leads to excessive Ca2+ influx which lead to 
neuronal death, it is attractive to think that blockade of these receptors can be a potential 
neuroprotective strategy. In fact, the NMDA receptor antagonist APV provides some 
neuroprotection even when added after excitotoxic stimulation with glutamate (Choi et 
al., 1988). Similar results were also obtained with the non-competitive NMDAR 
antagonist 5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine hydrogen 
maleate (MK-801). MK-801 showed robust neuroprotective effects in the CA1 region of 
the hippocampus even if added 1 h after  transient global ischemia (Buchan et al., 1990). 
The use of neurotrophic factors can also be a neuroprotective strategy. Pre-incubation for 
24 h with brain-derived neurotrophic factor (BDNF) or with neurotrophin-3 (NT-3) 
partially protected cultured hippocampal neurons from glutamate-induced death of 
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hippocampal neurons (Almeida et al., 2005). A small molecule domain derived from 
BDNF was also shown to be neuroprotective in rats subjected to TBI (Massa et al., 2010).  
Although the use of NMDA receptors antagonists in the clinic can be 
neuroprotective after an ischemic episode, by halting cell death pathways, their broad and 
unspecific inhibition can also interfere with cell survival and homeostatic mechanisms. In 
fact, there are reports showing that NMDA receptors antagonists can induce side effects 
such as psychosis, nausea, vomiting, memory impairment and neuronal cell death 
(Gardoni et al., 2006). One way to surpass this is to specifically target cell death pathways 
that are activated upon excessive Ca2+ influx. Accordingly, siRNA against PSD-95 was 
shown to protect cultured cortical cultures against NMDA toxicity (Cui et al., 2007) and, 
more specifically, disruption of nNOS-PSD-95 interaction, even after 3 h of an ischemic 
episode, can offer significant neuroprotection without affecting other neuronal functions 
(Zhou et al., 2010). 
 Preconditioning (PC) has also been proposed as a protective mechanism against 
stroke. The term PC is used when a certain stimuli applied to the brain, below the 
threshold of damage, is capable of protecting the organ against a severe stimuli (Dirnagl 
et al., 2003). There are two accepted time windows for PC: a rapid time window has been 
shown to exist 30 min to 1 h following PC, which is regulated by protein degradation 
mechanisms (further discussed in section 1.9). In contrast, delayed tolerance is induced 
24-72 h following PC, by a mechanism that is sensitive to protein synthesis inhibitors and 
characterized by an upregulation of anti-apoptotic proteins such as Bcl-2 (Meller et al., 
2005; Meller et al., 2006). 
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1.6- Experimental models of ischemia 
A number of experimental in vivo and in vitro models are currently used to study 
brain ischemia. In vivo studies have the advantage of preserving neuronal circuitry, 
keeping the cells in their native environment and preserving the cross-talk between 
neurons and other cell types. In contrast, in vitro studies are more targeted to assess 
molecular and biochemical changes in the cell, taking advantage of cell cultures as 
experimental models.  
1.6.1- In vivo models 
A global ischemic insult to the brain consists of a brief but nearly complete 
cessation of cerebral blood flow resulting from a permanent occlusion of the vertebral 
arteries and transient occlusion of the common carotid arteries (the four vessel occlusion, 
4-VO, in rats), or by transient occlusion of the common carotid arteries (the two-vessel 
occlusion, 2-VO, in gerbils and mice), followed by reperfusion (Small et al., 2000). 
Focal ischemia is the animal model that most closely mimics stroke or cerebral 
infarction in humans (Nagasawa et al., 1989), and is produced by occlusion of the middle 
cerebral artery (MCAO) (McAuley et al., 1995). Arterial occlusion can be permanent, i.e. 
the arterial blockade is maintained throughout the experiment, or temporary, when 
occlusion is performed up to 3 h and is followed by reperfusion.  
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1.6.2- In vitro models 
Incubation of dissociated cell cultures or organotypic cultures under conditions of 
oxygen and glucose deprivation (OGD) provides an in vitro model of global ischemia 
(Goldberg et al., 1993). In vitro OGD is performed in primary cultures of neurons from 
the neocortex, hippocampus, cerebellum and hypothalamus of embryonic mice. At 7-14 
days in vitro (DIV) the culture medium is exchanged with a deoxygenated and glucose-
free salt solution to induce OGD. The cultures are deprived of oxygen and glucose for a 
certain period of time and then transferred to the original culture medium in normoxic 
conditions. Similar experiments have been performed using hippocampal organotypic 
slice cultures (Gerace et al., 2012) which mimic more closely the cellular diversity found 
in the hippocampus and preserves the neuronal circuits. 
1.7- The ubiquitin proteasome system (UPS) 
1.7.1- Protein homeostasis 
Cells are constantly challenged by environmental and physiological stress 
conditions that can ultimately lead to protein misfolding. Similarly, protein synthesis is 
not a highly efficient process and can also contribute to increase the amount of misfolded 
proteins, particularly when proper folding is unsuccessful. In an early attempt to quantify 
the amount of newly synthetized proteins that contains errors, Schubert and co-workers 
found that more than 30% of them are defective (Schubert et al., 2000).  
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Unfolded proteins can be highly toxic to cells mainly because of their tendency to 
form intracellular aggregates, and this has been attributed to the exposure of certain 
hydrophobic residues (Kriegenburg et al., 2012). Protein misfolding is counteracted by 
protective mechanisms based on molecular chaperones. They are responsible to identify 
unfolded proteins, and refold them to their native state (Kriegenburg et al., 2012). When 
protein misfolding reaches a certain threshold, and molecular chaperones are no longer 
capable to refold unfolded proteins, proteins are targeted for degradation. 
Cells rely on two major proteolytic systems to eliminate unstable proteins or those 
that need to be turned-over, the Ubiquitin-Proteasome System (UPS) and the lysosomal 
system. In the former mechanism, substrate proteins are targeted to the 26S proteasome 
by the covalent attachment of multiple ubiquitin proteins (Hershko et al., 1998) whereas 
in the lysosomal system portions of cytoplasmic content are degraded in the lysosomal 
lumen by hydrolases (Wong et al., 2010).  
1.7.2- Ubiquitin 
Ubiquitin is a small, heat-stable and highly conserved 76-amino acid protein 
which can be covalently attached to other proteins (Hershko et al., 1998; Fang et al., 
2004; Ikeda et al., 2008). This ~8.5 kDa protein, expressed in eukaryotic cells is 
considered a post-translational modifier (Nalepa et al., 2006), and provides the advantage 
of regulating a protein function, in a spacial and temporal manner, without affecting 
transcription. 
The seven lysine (Lys) residues contained in ubiquitin (Lys6, Lys11, Lys27, 
Lys29, Lys33, Lys48 and Lys63) and the C-terminal Glycine (Gly) (Figure 6) are 
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essential for polyubiquitin chain formation (Grabbe et al., 2011), and to control the 
myriad of different biological functions that ubiquitin possesses (Meller et al., 2009).   
 
 
 
Figure 6- Ubiquitin structure. Ubiquitin is synthesized as a large precursor protein, whose C- 
terminus is cleaved by a deubiquitinating enzyme (DUB) to reveal a C-terminus glycine 
residue. Seven lysine residues are present in the primary amino acid structure of ubiquitin, 
which allows multiple potential polyubiquitin chain linkages. From all type of polyubiquitin 
chains, K48 (29.1%), K11 (28%) and K63 (16.3%) are the most abundant (adapted from Xu et 
al., 2009). 
 
 
A single ubiquitin molecule can be added to the substrate protein on one 
(monoubiquitination) or multiple (multi- monoubiquitination) sites (Ye et al., 2009). 
Furthermore, ubiquitin can also be repeatedly attached to ubiquitin molecules, through a 
single type of lysine residue (a process termed homotypic polyubiquitylation), or through 
several distinct lysines in the ubiquitin monomers thereby forming mixed chains (Figure 
7) (Ikeda et al., 2008; Kulathu et al., 2012). All the countless possibilities to add ubiquitin 
to a protein offers the possibility to increase the variety of ubiquitin-mediated post-
translational modifications (Glickman et al., 2002), thus regulating, in a spatial and 
temporal manner, the physiological role of a specific protein.  
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Figure 7- A schematic model of possible ubiquitin chains on a target protein. A) 
Homotypic polyubiquitin chains with lysine 6 (Lys 6)-, Lys 11-, Lys 27-, Lys 29-, Lys 33-, Lys 
48- or Lys 63-linked ubiquitin molecules.  B) Mixed-linkage atypical chains are formed by the 
use of different lysines for sequential ubiquitin conjugation, leading to the formation of 
bifurcated chains (adapted from Ikeda et al., 2008). 
 
 
Modification by monoubiquitination is involved in histone regulation and in 
targeting membranar proteins to the lysosome (Hicke et al., 2001). In contrast, formation 
of polyubiquitin (polyUb) chains through the Lys48, which have been coined as the 
“canonical” ubiquitin chains, target proteins for proteasomal degradation in a process that 
requires at least four ubiquitin molecules (Fang et al., 2004; Ye et al., 2009; Xu et al., 
2009; Lander et al., 2012). Non-canonical polyUb chains, such as Lys63 linked chains, is 
associated with non-proteolytic functions such as DNA repair, kinase activity modulation 
(Pickart et al., 2004), regulating plasma membrane protein internalization through the 
endocytic pathway, and deliver of internalized proteins for lysosomal degradation 
(Grabbe et al., 2011; Wagner et al., 2011). The importance of Lys11-linked polyUb 
chains in regulating cell cycle has been recently updated (Wickliffe et al., 2011), and 
along with Lys6, Lys27 and Lys29, Lys33-linked polyUb chains can also direct proteins 
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for proteasomal degradation (Xu et al., 2009; Kulathu et al., 2012). Surprisingly, it has 
been shown that mono-and multi-monoubiquitination can also be proteasomal 
degradative signals (Guterman et al., 2004; Boutet et al., 2007; Dimova et al., 2012).  
1.7.3- The Ubiquitination Machinery 
 As a post-translational modification, the ubiquitination process, i.e., the process of 
adding ubiquitin to a substrate protein, and the removal of these ubiquitin molecules at 
later point is a finely tuned process governed by a cascade of ubiquitination enzymes and 
by deubiquitinating enzymes (DUBs), respectively. Almost 3% of the human genome is 
devoted to the ubiquitination machinery showing the importance of this process in cell 
survival and homeostasis. 
Protein ubiquitination occurs through a sequential action of three different classes 
of enzymes, E1 or ubiquitin activating enzyme, E2 or ubiquitin conjugating enzyme and 
E3 or ubiquitin ligases (Figure 8). The human genome encodes for 2 E1s, ~40 E2s and 
~650 E3s (Ye et al., 2009; de Bie et al., 2011).  
E1 is the first enzyme involved in the ubiquitination cascade; it binds to Mg2+-
ATP and subsequently to ubiquitin in order to activate its C-terminal Gly residue. ATP 
hydrolysis generates an ubiquitin adenylate, followed by ubiquitin transference to a Cys 
residue of E1 through a thiol-ester linkage, with the release of adenosine monophosphate 
(AMP) (Hershko et al., 1983). Since this activating step is sequentially repeated, each 
fully loaded E1 carries two molecules of ubiquitin, one as a thiol-ester and the other as an 
adenylate (Fang et al., 2004). Activated ubiquitin is then transferred to a conserved core 
domain of ~150 residues (ubiquitin-conjugating (UBC) domain) of an E2 conjugating 
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enzyme, that includes an invariant cysteine responsible for accepting ubiquitin from E1 
(Fang et al., 2004; Ye et al., 2009). In the third step, ubiquitin is transferred, specifically, 
to a substrate protein by an E3 ligase. Two different classes of E3 ligases interact with E2 
conjugating enzymes and can serve either as catalytic intermediate, or mediate the direct 
transfer of ubiquitin to the substrate. Homologous to E6-AP Carboxyl Terminus (HECT) 
E3 ligases serves as intermediate ubiquitin acceptors through the formation of a thiol-
ester linkage between ubiquitin and the Cys residue in the HECT domain before ubiquitin 
is attached to the substrate (Fang et al., 2004; de Bie et al., 2011). On the other hand, 
Really Interesting New Gene (RING) E3 ligases act only as a “scaffold” proteins forming 
an E2-substrate protein complex allowing the direct transfer of ubiquitin (Fang et al., 
2004; de Bie et al., 2011). Despite the differences in the mechanisms of ubiquitin 
transference to the substrate proteins, both types of E3 ligases culminate in the formation 
of an isopeptide bond between the C-terminal Gly of ubiquitin and a ε-NH2 group of an 
internal Lys of the substrate. However, it was recently found that ubiquitin can also be 
added to other residues (de Bie et al., 2011). 
 
Figure 8- The ubiquitylation pathway. Free ubiquitin is activated in an ATP-dependent 
manner with the formation of a thiol-ester linkage between E1 (activating enzyme) and the 
carboxyl terminus of ubiquitin. Ubiquitin is transferred to an E2 (conjugating enzyme) cysteine 
(Cys) active site. The E3 ligase enzyme brings the protein to be ubiquitinated to the vicinity of 
a loaded E2 and mediates the transfer of ubiquitin to the protein. In the case of a RING ligase, 
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the ubiquitin-charged E2 binds to the E3 and transfers the activated ubiquitin moiety directly to 
the substrate that is also bound to the E3. In the case of HECT domain ligases, ubiquitin is 
transferred from the E2 to a Cys residue in the E3 and then to the substrate (Fang et al., 2004). 
1.7.4- Deubiquitinating enzymes (DUBs) 
The ubiquitination process can be counteracted by DUBs. Five major classes of 
DUBs have been described: Ubiquitin C-terminal hydrolases (UCHs), Ubiquitin-specific 
proteases (USPs), Machado-Joseph disesase protein domain proteases, ovarian tumour 
proteases and JAMM motif proteases (Love et al., 2007). Almost all DUBs are cysteine 
proteases, except the JAMM family which are metalloproteases (Todi et al., 2011). DUBs 
may be associated with the 26S proteasome, however, most of them have a cytosolic 
localization. Their overall function is to cleave ubiquitin-linked molecules after C-
terminus of the last residue of ubiquitin (Gly76) being essential to i) maintaining 
monomeric ubiquitin pool, either by cleaving the ubiquitin precursor or by trimming 
polyUb chains; ii) rescue proteins targeted for degradation, allowing the cell to adapt 
quickly to physiological changes, and iii) prevent ubiquitin-proteasome dependent 
degradation (Guterman et al., 2004; Komander et al., 2009).  
1.7.5- The 26S proteasome 
The 26S proteasome is a 2.5 MDa multisubunit complex (Figure 9) responsible for 
controlled ATP-dependent degradation of polyubiquitinated proteins (Xie et al., 2010). It 
is composed of a catalytic 20S core particle (CP or 20S proteasome) associated with one 
(RP1CP) or two (RP2CP) 19S regulatory particles (RP or 19S proteasome) (Figure 9) that 
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are responsible for detecting, deubiquitylating and unfolding ubiquitinated proteins (da 
Fonseca et al., 2008; Djakovic et al., 2012). However, the physiological roles of RP1CP 
and RP2CP proteasomes are not fully understood. 
 
 
Figure 9- The 26S Proteasome, a catalytic 20S core particle (yellow) capped at both/one 
edges by a 19S regulatory particle (blue) (Baumeister et al., 1998). 
 
 
The 26S proteasome consists of at least 66 resident subunits and associated 
proteins, e.g., E3 ligases, assembling factors, such as molecular chaperones and others 
(Leggett et al., 2002; Xie et al., 2010; Tai et al., 2010). In the cell the proteasomes are 
found both in cytoplasmic and nuclear fractions, and a constant trafficking between these 
two compartments seems to occur during cell cycle (Wojcik et al., 2003). Once a protein 
is committed for proteasomal degradation, with at least four ubiquitin moieties and, 
proper polyUb chain (Glickman et al., 2002; Lander et al., 2012), its binding and 
subsequent deubiquitination promotes the translocation and degradation by the 
proteasome (Figure 10). At the end, small peptides ranging from 2 to 20 amino acids and 
free ubiquitin are generated (Glickman et al., 2002). 
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Although recognition of ubiquitinated proteins is a stochastic process, several 
proteins such as Rad23 and Dsk2 (Husnjak et al., 2008) have been shown to act as 
shuttling factors and direct ubiquitinated proteins to the 26S proteasome (Figure 10). 
Binding to the proteasome is driven by the N-terminal ubiquitin-like domain (UBL), 
while the C-terminal ubiquitin associated domain (UBA) binds ubiquitin (Rosenzweig et 
al., 2012). 
 
 
Figure 10- Overview of the Ubiquitin-Proteasome System (UPS). Polyubiquitinated 
proteins, with at least four ubiquitin moieties, most commonly joined through the Lys48 
residue are recognized by the 19S regulatory particle and subsequently deubiquitinated. In 
addition, polyubiquitinated proteins can be directly targeted to the proteasome in association 
with several adaptor or shuttling factors (Rad23, Dsk2 and others). After polyubiquitin chain 
removal, the protein is unfolded by specific 19S RP unfoldases and degraded to small peptides 
by the 20S catalytic core. In the end, free ubiquitin is spared from degradation and is 
regenerated (Ravid et al., 2008).  
1.7.6- The 20S proteasome 
The 20S proteasome is a ~670 kDa barrel-shaped structure composed of 28 
subunits arranged in a four stacked ring structure: two α1-7 inner rings and two β1-7 outer 
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rings (Figure 11A) (da Fonseca et al., 2008). In the center of the ring, there is a narrow 
pore where a protein targeted for degradation can enter in an unfolded state. In the free 
CP, this pore is closed by the N-terminus of the α-subunits, namely α2, α3 and α4 (Xie et 
al., 2010). However, the truncation of the α3 N-terminal is enough to keep the pore open 
and increases the degradation of small peptides (Peth et al., 2009).  
Besides closing the pore, α-subunits are also responsible for compartmentalizing 
the catalytic β-subunits thereby preventing uncontroled cleavage of cytosolic proteins. 
The β ring also forms a central chamber where the peptidylglutamyl-like (cleaving after 
acidic residues), trypsin-like (cleaving after basic residues) and chymotrypsin-like 
(cleaving after hydrophobic residues) activities of the 20S proteasome are mediated by 
the β1, β2 and β5 subunits, respectively (Figure 11 B) (Groll et al., 1997). 
 
 
Figure 11- Structure of the 20S proteasome. A) The 20S proteasome consists in two inner β-
rings and two outer α-rings juxtaposed, forming a barrel-shaped structure. Each ring is 
composed by seven subunits (α1-7 and β1-7). While the only function of the α-ring is to close 
the pore through its N-terminus region, the β-ring is responsible to the degradative function of 
this catalytic particle. B) The peptidylglutamyl-like, trypsin-like and chymotrypsin-like 
activities of the 20S proteasome are catalyzed by the β1, β2 and β5 subunits, respectively 
(adapted from Baumeister et al., 1998). 
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1.7.7- The 19S proteasome 
 Another component of the 26S proteasome is the 19S regulatory particle (RP), a 
~700 kDa multisubunit complex composed of 19 subunits. The 19S proteasome serves to 
recognize ubiquitinated proteins, deubiquitinate and unfold the substrates in order to 
make them suitable to enter into the 20S catalytic pore. It is divided in two biochemically 
distinct sub-complexes: the lid and the base (Figure 12) (Hershko et al., 1998; Sakata et 
al., 2012). The lid consists of eight non-ATPase subunits, Rpn3, Rpn5-9, Rpn12 and 
Rpn11 (a DUB enzyme). The base contains six distinct AAA+ ATPases, Rpt1-6, and four 
non-ATPase subunits, Rpn1, Rpn2, Rpn10 and Rpn13 (Figure 12) (Lander et al., 2012). 
 
 
Figure 12- Schematic diagram of the 26S proteasome. While the 20S catalytic particle is 
responsible for protein degradation, the 19S regulatory particle (RP) possesses a more refined 
role in this degradative machine. The RP can be further subdivided in two distinct sub-
complexes: the lid and the base. The lid is composed of eight non-ATPase subunits, Rpn3, 
Rpn5-9, Rpn11 and Rpn12, whereas the base is comprised by six distinct AAA+ ATPases, 
Rpt1-6, in addition to four non-ATPase subunits, Rpn1, Rpn2, Rpn10 and Rpn13 (Xie et al., 
2010). 
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The interaction of polyubiquitinated proteins with RP base occurs on two intrinsic 
proteins, Rpn10 and Rpn13, located in the apical part (Sakata et al., 2012). Rpn10 binds 
ubiquitin conjugates through its C-terminus Ubiquitin-Interacting Motif (UIM), and a 
similar function is mediated by the Rpn13 subunit through a conserved amino-terminal 
region named pleckstrin-like receptor for ubiquitin (Pru) domain (Elsasser et al., 2004; 
Husnjak et al., 2008; Schreiner et al., 2008). The Pru domain is also important to attach 
Rpn13 to the proteasome (Schreiner et al., 2008). 
Rpn1 and Rpn2 are large scaffold proteins of the lid. While Rpn1 is responsible 
for binding shuttling factors such as Rad23, Dsk2, Dd1 (Elsasser et al., 2002; Elsasser et 
al., 2004; Rosenzweig et al., 2012), and the non-obligatory deubiquitinating enzyme 
Ubp6/Usp14 (Elsasser et al., 2004; Rosenzweig et al., 2012), Rpn2 only binds the Rpn13 
subunit (Schreiner et al., 2008; Rosenzweig et al., 2012).  
The ATPase ring of the 19S proteasome is arranged in a spiral case and constitutes 
the driving force to unfold and pull the proteins targeted to be degraded inside the 
catalytic core (Lander et al., 2012). The Rpt2 subunit appears to be the only one required 
for CP opening and substrate entry (Kohler et al., 2001). Two independent studies 
attributed a role for the base ATPases, in preventing protein aggregation, by acting as 
chaperones, mediating protein refolding and not unfolding (Braun et al., 1999), and the 
Rpt5 subunit may also bind polyUb chains as shown by crosslinking studies (Lam et al., 
2002). 
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Figure 13- Overall model for the recognition, deubiquitination and unfolding of proteins 
promoted by the 19S regulatory particle.  A K48-linked tetra-ubiquitin chain (magenta) is 
conjugated to the substrate (red) and bound to the pleckstrin-like receptor for ubiquitin (Pru) 
domain of the ubiquitin receptor Rpn13 (orange). The substrate is positioned for 
deubiquitination by Rpn11 (green), and its unstructured initiation region is engaged by the 
translocation machinery comprised by the Rpt1-6 subunits (cyan). A polyubiquitin chain could 
alternatively bind to the ubiquitin-interacting motif (UIM) of Rpn10 (yellow) or interact with 
both receptors simultaneously. The DUB Ubp6 is localized further from the central pore, in a 
position to trim excess ubiquitin chains or to prevent unintentionally degradation of 
ubiquitinated proteins (Lander et al., 2012). 
1.8- The Role of the UPS in neuronal cells 
Neurons are a post-mitotic and very specialized cell type, and several components 
of the UPS are present in both pre- and post-synaptic compartments. In the nervous 
system the UPS regulates several aspects of synaptic function, such as axon growth, 
synapse formation and elimination, presynaptic neurotransmission and LTP/LTD (Yi et 
al., 2007; Haas et al., 2008; Cajigas et al., 2010), being the major proteolytic system 
responsible for maintaining protein homeostasis. Rat cortical cell extracts possess a 
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higher proportion of 26S proteasomes (~57%), when compared to HeLa cell (~39%) and 
to rat liver/kidney cell extracts (~51%) (Tai et al., 2010). This points out the importance 
of the UPS in the nervous system, and suggests that selective protein degradation is a 
highly controlled process. 
Synaptic activity can alter significantly the neuronal proteome within minutes 
after downstream receptor activation. In fact, several components of the UPS can also be 
regulated upon NMDAR activation. Bingol and others reported that increasing synaptic 
activity enhances proteasome activity and induces a redistribution of the 26S proteasome 
reporter Rpt1-GFP from dendritic shafts to dendritic spines (Bingol et al., 2006). These 
effects were prevented by CaMKIIα inhibition (Djakovic et al., 2009) and CamKII 
knockdown with siRNA (Bingol et al., 2010). Similarly, activation of NMDARs also 
activates the Ubiquitin C-terminal Hydrolase L1 (UCH-L1), increasing free monomeric 
ubiquitin levels (Cartier et al., 2009).  
Postsynapticaly, the UPS is responsible for the regulation of the levels or 
localization of several synaptic components (Figure 14). For example, the NMDAR 
subunits, GluN1 and GluN2B, are regulated in an activity-dependent manner by the Fbx2 
and Mind Bomb-2 (Mib2) E3 ligases, respectively (Kato et al., 2005; Jurd et al., 2008). 
The postsynaptic scaffold proteins PSD-95, Shank and GKAP undergo selective activity-
dependent ubiquitination (Ehlers et al., 2003), and while the Murine-Double Minute 2 
(Mdm2) is the putative E3 ligase for PSD-95 (Colledge et al., 2003), knockdown of 
endogenous TRIM3 E3 ligase increases the protein levels of GKAP and Shank (Hung et 
al., 2010), suggesting that these two proteins share a common E3 ligase. The UPS also 
mediate the internalization of several membrane-associated synaptic proteins. The initial 
studies showed that AMPA-induced internalization of AMPAR mediated by AMPA was 
abolished by the proteasome inhibitor MG132 but no ubiquitination of AMPA receptor 
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subunits was observed (Patrick et al., 2003). Later studies suggested that this 
internalization was due to a reduced stabilization of AMPA receptors into synaptic sites 
due to by PSD-95 degradation (Colledge et al., 2003). Recent studies showed that Nedd4 
(neuronal-precursor cell-expressed developmentally downregulated gene 4) is the putative 
E3 ligase for GluA1 (Schwarz et al., 2010), and knockdown of Nedd4 prevented GluA1 
C-terminal K868 residue ubiquitination, abolishing AMPARs internalization (Lin et al., 
2011). 
 
 
 
Figure 14- Examples of post-synaptic components regulated by the UPS. Several 
components of the UPS are present in the post-synaptic site such as deubiquitinating enzymes, 
26S proteasomes, free ubiquitin and several E3 ligases. From the aforementioned components, 
Neuronal-precursor cell-expressed developmentally downregulated gene 4 (Nedd4), Fbx2, 
Mind Bomb-2 (Mib2) and Murine-Double Minute 2 (Mdm2) have been shown to physically 
interact and ubiquitinate GluA1, GluN1, GluN2B, PSD-95, respectively. The TRIM3 E3 ligase 
may regulate the levels of Shank and GKAP. Additionally, these components are negatively 
regulated by an increase in synaptic activity (adapted from Bingol., 2011). 
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1.9- Proteasome, excitotoxicity and neuroprotection 
One of the major hallmarks in neurodegenerative diseases is the deposition of 
misfolded proteins in insoluble fractions. This is best described in Alzheimer´s disease, 
Parkinson´s disease, Creutzfeldt-Jakob disease, Polyglutamine expansion-related 
diseases, and is often correlated with mutations in several UPS components (Ciechanover 
et al., 2003).  
As ATP depletion occurs in neurons upon brain ischemia, it is reasonable to 
expect and impairment of the UPS, an ATP-dependent proteolytic system. In fact, it was 
shown that after 10 min of transient forebrain ischemia the chymotrypsin-like activity of 
the 26S proteasome in the gerbil cortex was reduced by 50%, whereas after 30 min of 
recovery the activity of the 20S proteasome was increased (Kamikubo et al., 1996). 
Moreover, using the same model, other authors reported a recovery in proteasome activity 
in the cerebral cortex and dentate gyrus (DG) at later time points, while in certain 
vulnerable areas, namely the CA1 region of the hippocampus, showed a sutained decrease 
in proteasome activity. In fact, following a transient forebrain ischemia there is a 
disassembly of the 26S proteasome into its major components, RP and CP, and in the 
CA1 region, the 26S proteasome is not fully able to reassemble, indicating irreversible 
biochemical changes (Asai et al., 2002). Furthermore, recent results from our laboratory 
suggest that excitotoxic glutamate stimulation also promotes the dissociation of the 26S 
proteasome decreasing its overall activity. This effect is likely due to the activation of 
extrasynaptic NMDAR and is partly mediated by caspases/cathepsins (unpublished data). 
In addition to proteasome dysfunction, brain ischemia also induces protein 
aggregation. Several reports have shown an increase in protein aggregates in the rat 
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hippocampal CA1 region aggregates 4 h after reperfusion, following 15 min of transient 
forebrain ischemia. In contrast, no protein aggregation was observed in the hippocampal 
DG under the same condition (Hu et al., 2000). Other studies also performed in rats, 
showed an accumulation of ubiquitinated proteins (ubi-proteins), chaperones, ribosomal 
proteins and the 26S proteasome in Triton-insoluble fractions during the reperfusion 
period, as well as a depletion of free ubiquitin (Hu et al., 2000; Hu et al., 2001; Asai et al., 
2002; Liu et al., 2005).  
 Proteasome inhibition can also be used as a therapeutical strategy to reduce brain 
infarction after ischemia. Velcade is one of the available proteasome inhibitors used for 
relapsed, refractory multiple myeloma. In a  rat model of focal cerebral ischemia, Velcade 
reduced the infarction volume even when applied 2 h after MCAO (Henninger et al., 
2006), and similar results were observed with another proteasome inhibitor MLN519 
(Williams et al., 2006). The neuroprotective effects observed with these proteasome 
inhibitors were attributed to a reduction in the activity of the Nuclear-Factor kappa B 
(NF-kB) pathway, a well-known transcription factor capable of regulating the 
inflammatory response (Wojcik et al., 2004). The UPS was also found to be involved in 
the rapid neuroprotective effects of ischemic tolerance, since proteasome inhibition with 
MG132 30 min after a non-harmful insult but prior to harmfull ischemia, obliterated the 
neuroprotective effect in a cortical cell culture (Meller et al., 2006). The authors also 
found that degradation of the pro-apoptotic Bcl-2 family member Bim is a key event for 
rapid ischemic tolerance (Meller et al., 2006).  
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During brain ischemia, the interruption of blood flow to the brain leads to a 
massive release of the excitatory neurotransmitter glutamate, resulting in an excessive 
activation of ionotropic glutamate receptors. Overactivation of glutamate receptors 
promotes an intracellular Ca2+ overload, which leads to cell death, and this is termed 
excitotoxicity (Choi et al., 1987). During OGD, a well-established in vitro model for 
transient global ischemia, the excessive Ca2+ influx leads to the activation of several 
proteases, including calpains and caspases, which cleave several intracellular 
components leading ultimately to cell death (Goldberg et al., 1993; Takano et al., 2005). 
Additionally, the UPS has been shown to be downregulated and disassembled into its 
major components, 30 min after a 10 min period of transient forebrain ischemia in 
gerbils (Kamikubo et al., 1996; Asai et al., 2002). However, how overactivation of 
glutamate receptors observed in brain ischemia contributes to the downregulation of the 
UPS is not known. Taking all these points into account, the main goals of this work 
were: i) to investigate how excitotoxic stimulation affects the proteasome activity in 
primary cultures of hippocampal neurons, ii) to evaluate hippocampal cell death 
promoted by proteasome inhibition and iii) to establish and characterize a new protocol 
for OGD using cortical cell cultures to investigate the effect of in vitro ischemia on the 
UPS. 
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Materials 
Neurobasal medium, fetal bovine serum (FBS), horse serum (HS), gentamycin, 
trypsin and B27 supplement were acquired from GIBCO Invitrogen. Neurocult® SM1 
supplement was bought from Stemcell Technologies. Minimum essential medium Eagle 
(MEM), kynurenic acid, dithiothreitol (DTT) as well as the proteases inhibitors 
phenylmethylsulfonyl fluoride (PSMF), Chymostatin, Leupeptin, Antipain and 
Pepstatin (CLAP, stock solution 1 mg/mL), and dimethyl sulfoxide (DMSO) were 
purchased by Sigma-Aldrich. 26S and 20S proteasome inhibitors, MG132 and clasto-
Lactacystin β-lactone, respectively, were both acquired from Calbiochem (EMD 
Chemicals), while Ubiquitin Aldehyde (Ub-Ald), a deubiquitinating enzime (DUB) 
inhibitor, was obtained from Boston Biochem. The enhanced chemifluorescence 
substrate (ECF) was purchased from GE Healthcare, the fluorescent mounting medium 
was from DAKO and Polyvinylidenedifluoride (PVDF) membranes were from 
Millipore. The fluorogenic peptide Suc-LLVY-AMC was from Peptide Institute. Protein 
quantification kits, namely Bicinchoninic Acid (BCA) and the BioRad kit were obtained 
from Pierce, as a part of Thermo Fisher Scientific, and from BioRad, respectively. The 
lactate dehydrogenase (LDH) kit was from Promega. All other chemicals/reagents were 
from Sigma-Aldrich, Merck, BioRad or Invitrogen. 
Antibodies 
The anti-green fluorescence protein (anti-GFP) polyclonal antibody was 
purchased from MBL International and the monoclonal anti-β-tubulin antibody was 
from Sigma. Anti-ubiquitin and anti α-spectrin were both from DAKO and Millipore, 
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respectively. The alkaline phosphatase-conjugated anti-rabbit and anti-mouse secondary 
antibodies, raised in goat, were obtained from GE Healthcare and from Jackson Immuno 
Research. 
Experimental Procedures 
Primary Hippocampal cultures 
Primary cultures of rat hippocampal neurons were prepared from the hippocampi 
of E18-E19 Wistar rat embryos, after treatment with trypsin (0.06%, 15 min at 37⁰C 
Paisley, UK) in Ca2+- and Mg2+-free Hank´s Balanced Salt Medium (HBSS; 5.36 mM 
KCL, 0.44 mM KH2PO4, 137 mMNaCl, 4.16 mM NaHCO3, 0.34 mM Na2HPO4.2H2O, 
5 mM glucose, 1mM sodium pyruvate, 10 mM HEPES and 0.001% Phenol Red). The 
hippocampi were then washed with HBSS containing 10% fetal bovine serum (GIBCO 
Invitrogen), to stop trypsin activity, washed with HBSS medium, to avoid the serum-
dependent development of glial cells, and then transferred to Neurobasal medium 
(GIBCO Invitrogen) supplemented with B27 supplement (1:50 dilution, GIBCO 
Invitrogen), 25 µM glutamate, 0.5 mM glutamine and 0.12 mg/mL gentamycin. The 
cells were mechanically dissociated in this solution and plated in 6-well plates (90x103 
cells/cm2) or 24-well plates (80x103 cells/cm2), depending on the type of experiment, 
coated with poly-D-lysine (0.1 mg/mL). The cultures were maintained in a humidified 
incubator with 5% CO2/95% air, at 37⁰C, for seven days, the time required for 
maturation of hippocampal neurons. 
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Primary cortical cultures 
Primary cultures of rat cortical neurons were prepared from the cortices of E18-
E19 Wistar rat embryos. Briefly, cortices where washed with ice-cold HBSS three and 
five times, prior and after trypsin (0.06%, 15 min at 37⁰C) treatment, respectively. Cells 
were mechanically dissociated, no more than 10-15 times with HBSS. After ccounting, 
the cells were plated with Neuronal Plating Medium (MEM supplemented with 10% 
horse serum, 0.6% glucose and 1mM pyruvic acid) for 2-4 h in 6- or 24-well plates 
(94.7x103 cells/cm2) coated with poly-D-lysine (0.1 mg/mL). After this period, the 
plating medium was removed and replaced by Neurobasal medium supplemented with 
SM1 supplement (1:50 dilution), without glutamate, 0.5 mM glutamine and 0.12 mg/mL 
gentamycin. After 2-3 days in culture, division of glial cells was halted by addition of 
10 µM 5-FdU-NOAC (5-FDU) to the medium. The culture were maintained in a 
humidified incubator with 5% CO2/95% air, at 37⁰C, for 14-15 days, as mentioned in 
the figure captions. 
Oxygen-Glucose Deprivation (OGD) assays 
The protocols used for OGD were adapted from D. Choi and co-workers 
(Goldberg et al., 1993; Grabb et al., 2002) with some modifications. Cortical neurons 
(14-15DIV) were incubated for 2h in a balanced salt solution (BSS: 116 mMNaCl; 
5.4mM KCL; 0.8 mM MgSO4; 1.0 mM NaH2PO4; 26.2 mM NaHCO3; 1.8 mM CaCl2; 
5mg/L phenol red, pH 7.3), and supplemented with 25 mM glucose (Sham condition) or 
with 25 mM sucrose (OGD condition). Prior to use, OGD medium was first gased with 
N2 for 5 min, to remove residual oxygen, and maintained overnight in an oxygen 
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deprived chamber containing 5% CO2, 7.5% H2, 87.5% N2. The sham medium was 
maintained overnight in a humidified incubator with 5% CO2/95% air. Cells were 
exposed to Sham or OGD media for 2 h and then returned to the initial culture 
conditioned medium for the time mentioned in the figure captions, before preparation of 
cell extracts or LDH assay. 
Excitotoxic stimulation with glutamate 
Hippocampal neurons (7 DIV) were exposed to 125 µM glutamate for 20 min in 
Neurobasal medium and further incubated in culture conditioned medium for 4 o 8 h. 
Under control conditions neurons were not exposed to glutamate. 
Transfection of hippocampal neurons with the calcium 
phosphate protocol 
UbG76V-GFP(Dantuma NP et al., 2000, Nat Biotechnol, 18, 538; Addgene 
plasmid 11941) was recombinantly expressed in hippocampal neurons (DIV5) cultured 
at a high-density by transfection using the calcium phosphate coprecipitation method as 
described previously, with minor modifications (Gomes et al., 2011). Briefly, 10-15 g 
of plasmid DNA were diluted in Tris-EDTA (TE) pH 7.3 and mixed with 2.5 M CaCl2. 
This DNA/TE/calcium mix was added to 10 mM HEPES-buffered saline solution (270 
mMNaCl, 10 mMKCl, 1.4 mM Na2HPO4, 11 mM dextrose, 42 mM HEPES), pH 7.2. 
The precipitates were allowed to form for 30 min, with vortex mixing every 5 min, 
protected from light, at room temperature to ensure that the precipitates had similar 
small sizes. Meanwhile, cultured hippocampal neurons were incubated with cultured 
conditioned medium with 2 mM kynurenic acid, a non-selective NMDA and 
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AMPA/kainate receptor antagonist. The precipitate was added drop-wise to each well 
and incubated at 37°C/ 5% CO2, for 3 h. The cells were then washed with acidic 10% 
CO2 equilibrated culture medium containing 2 mM kynurenic acid and returned to the 
37°C/5% CO2 incubator for 20 min. Finally, the medium was replaced with the initial 
culture-conditioned medium, and the cells were further incubated in a 37°C/5% CO2 
incubator for 48-72 h to allow protein expression. 
Hippocampal neuronal cell extracts 
Hippocampal neurons with 7 DIV were washed once with ice-cold phosphate-
buffered saline buffer (PBS; 137 mM NaCl, 2.7 mM KCL, 1.8 mM KH2PO4, 10 mM 
Na2HPO4.2H2O, pH 7.4). Cells werelysed with RIPA buffer, 100 µl/well (150 mM 
NaCl, 50 mM Tris-HCl, pH 7.4, 5 mM EGTA, 1% Triton, 0.5% DOC and 0.1% SDS, 
pH7.5) supplemented with a cocktail of protease inhibitors (0.1 mM PMSF, CLAP: 1 
μg/mL chymostatin, 1 μg/mL leupeptin, 1 μg/mL antipain, 1 μg/mL pepstatin; Sigma-
Aldrich), 1 mM dithyothreitol (DTT). For UbG76V-GFP expression experiments, RIPA 
buffer was also supplemented with MG132 (25 µM), a reversible proteasome inhibitor. 
The extracts were then sonicated for 1 minute with 6 pulses of 5 seconds each and 
centrifuged at 16 100 x g for 10 min at 4°C. After sonication and centrifugation, total 
protein in the supernatants was quantified using the  BCA method  and  then 
denaturated  with  2× concentrated  denaturating  buffer  (125  mM Tris,  pH  6.8,  100  
mM glycine, 4% SDS, 200 mM DTT, 40% glycerol, 3 mM sodium orthovanadate, and 
0.01% bromophenol blue), at 95ºC for 5 min. The proteins of interest were then 
analyzed by Western Blot. 
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Preparation of cell extracts for proteasome activity-related 
experiments 
For proteasome activity experiments, as well as for analysis of ubiquitinated-
proteins, 7 DIV cultured hippocampal neurons were washed once in ice-cold PBS and 
lysed with Lysis Buffer (1mM EDTA, 10 mM Tris-HCl pH 7.5, 20% Glycerol, 4mM 
DTT and 2 mM ATP; 100µl/well). As described above, cells were sonicated and 
centrifuged, and total protein content in the supernatants was quantified using the Bio-
Rad method. The protein concentration in the samples was equalized with Lysis buffer 
and the proteins were then denaturated  with  2× concentrated  denaturating  buffer  
(125 mM Tris,  pH  6.8,  100  mM glycine, 4% SDS, 200 mM DTT, 40% glycerol, 3 
mM sodium orthovanadate, and 0.01% bromophenol blue). The samples were used to 
evaluate proteasome activity or Western Blot analysis. 
Western Blot 
Protein were separated by SDS-PAGE, in 6%, 7.5% or 11% polyacrylamide 
gels, transferred to PVDF membranes in 10mM CAPS buffer with 10% of methanol 
(overnight, 4 °C, 40 V), and immunoblotted. The blocking of the membranes was 
performed with 5% non-fat dry milk, prepared in TBS supplemented with 0.1% Tween-
20 for 45 min. The membranes were then incubated with the appropriate primary 
antibodies (overnight at 4°C), washed, and exposed to alkaline phosphatase-conjugated 
secondary antibodies (1h at room temperature). Alkaline phosphatase activity was 
visualized by enhanced chemifluorescence (ECF) on the Storm 860 Gel and Blot 
Imaging System (GE Healthcare) and quantified using the ImageQuant software (GE 
Healthcare). The following primary antibodies were used: anti-ubiquitin (mono- and 
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polyubiquitinated conjugates; 1:1000), anti-GFP (1:1000), anti-spectrin (1:1000). Anti- 
β-tubulin was used as loading control (1:300000) in all experiments and the results 
expressed after normalization 
Stripping and reprobing of the membranes 
In order to reprobe membranes with additional primary antibodies, namely those 
used against β-tubulin, used as experimental loading control, ECF was removed by 
washing the membranes with TBS-T for 30-40 min. After this washing step, the 
membranes were washed for 5 min with 0.2 M NaOH and washed again, abundantly 
with water. Membranes were again blocked for 1 h, with 5% non-fat milk in TBS-T, 
and incubated with the anti-β-tubulin antibody (1:300000). Secondary antibodies were 
incubated for 1 h at room temperature. 
Proteasomal peptidase activity assay 
The chemotrypsin-like activity of the proteasome was assayed by monitoring the 
production of 7-amino-4-methylcoumarin (AMC) from the fluorogenic substrate Suc-
LLVY-AMC (25 µM; Peptide Institute, Inc, Osaka, Japan). Hippocampal cell extracts 
(17 µg of protein) were incubated with Suc-LLVY-AMC in 50 mM Tris-HCl (pH 8.0) 
and 0.5 mM EDTA, in a final volume of 100 µl. The release of fluorescent AMC was 
measured using a SPECTRAmax Gemini EM microplate reader (Molecular Devices), at 
an excitation and emission wavelengths of 360 nm and 460 nm, respectively, for 60 min 
at 37°C, at 5 min intervals. All the experiments were performed in the presence of 2 
mM ATP. Specific activity was determined by subtracting the activity measured in the 
presence of 10 µM MG132, a proteasome inhibitor. 
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Lactate dehydrogenase (LDH) assay 
After the OGD insult, the cells were further incubated in culture conditioned 
medium for the period of time mentioned in figure captions. The LDH leakage to the 
extracellular medium was evaluated by a colorimetric assay, using the CyoTox 96 Non-
Radioactive assay kit (Promega), according to the manufacturer´s instruction. Briefly, 
the extracellular medium was removed and diluted with an equal volume of H2O to a 
final volume of 100 µl, and 50 µl of substrate mix was added to the diluted sample, at 
room temperature, protected from the light. Incubation with the substrate was performed 
for 30 min and the reaction was stopped with 50 µl of stop solution. The activity of 
LDH was measured using a SPECTRAmax Gemini EM (Molecular Devices) 
microplate reader, at an excitation wavelength of 490 nm. The percentage of LDH 
released to the medium was determined as the ratio between LDH activity in the 
extracellular medium and total LDH activity (100% cell death) obtained by cell lysis. 
Nuclear morphology staining 
Hippocampal neurons were cultured for 7 days on poly-D-lysine-coated glass 
coverslips, at a density of 80x103cells/cm2. After the appropriate stimulus (see figure 
caption), cells were fixed for 20 min, at room temperature, in 4% sucrose/ 4% 
paraformaldehyde dissolved in PBS, washed once with ice-cold PBS and the nuclei 
were then stained with Hoechst 33342 (1µg/ml), for 10 min, protected from the light, at 
room temperature. After this, cells were washed once with ice-cold PBS and the 
coverslips were mounted with a fluorescent mounting medium (DAKO). Images were 
captured using a Zeiss Axiovert 200 fluorescent microscope coupled to an Axiocam 
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camera. Three independent coverslips were prepared for each experimental condition, 
and at least 200 cells were counted in each case. 
Statistical analysis 
Graphs and statistical analysis were performed using Graph Pad Prism 5. Results 
are presented as mean±S.E.M. of the indicated number of experiments and statistical 
analysis were assessed by Students t-test or one-way variance analysis (ANOVA) 
followed by the Dunnett’s and Bonferroni´s post test as mentioned in figure captions. 
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Excitotoxic glutamate stimulation downregulates the proteasome 
activity and induces hippocampal neuronal death 
Excitatory neurotransmission in mammalian brain is mainly driven by the 
excitatory neurotransmitter glutamate (Santos et al., 2009). This type of 
neurotransmission is thought to underlie many aspects related to learning and memory 
formation (Santos et al., 2009). However, overactivation of glutamate receptors can 
induce cell death (Choi et al., 1987; Almeida et al., 2005), and is associated with many 
pathological conditions, including stroke (Mattson et al., 2003). Also, in vivo models of 
stroke, such as transient forebrain ischemia, have shown a decrease in proteasome 
activity with a concomitant increase in protein aggregates (Ge et al., 2007). However, 
the mechanisms involved in the downregulation of the proteasome activity in brain 
ischemia have not been elucidated.  
In this study we evaluated the effect of excitotoxic stimulation with glutamate on 
the proteasome chymotrypsin-like activity, using the fluorogenic substrate Suc-LLVY-
AMC. Hippocampal neurons (7 DIV) were stimulated with 125 µM glutamate for 20 
min, and further incubated in cultured conditioned medium for different periods of time. 
Excitotoxic stimulation of hippocampal neurons induced a transient downregulation of 
the chymotrypsin-like activity of the proteasome, and the maximal effect was observed 
4-5 h after the insult (Figure 15A), when the activity of the proteasome was decreased to 
about 50% of the control (P<0.001). For longer incubation periods after the toxic insult 
the inhibition of the proteasome activity was not as significant.  
In additional experiments we measured the effect of stimulation with different 
concentrations of glutamate on the viability of cultured hippocampal neurons. 
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Hippocampal neurons were incubated with 10, 20, 50 and 125 µM glutamate and cell 
death was evaluated after 4 h of incubation in culture conditioned medium, by 
fluorescence microscopy and using Hoechst 33342. We observed a dose-dependent 
effect of glutamate, and the maximal effects obtained for 50 and 125 µM glutamate, 
which increased cell death to  54.4% (P<0.01) and 57.2% (P<0.01), respectively. Taken 
together, these results indicate that excitotoxic glutamate stimulation downregulates the 
chymotrypsin-like activity of the proteasome under conditions that induce hippocampal 
neuronal death. 
 
 
Figure 15- Effect of excitotoxic glutamate stimulation on proteasome activity. A) Hippocampal 
neurons (7 DIV) were stimulated with 125 µM of glutamate and further incubated with the conditioned 
medium for the indicated period of time. The proteasome chymotrypsin-like activity was evaluated by 
using the fluorogenic substrate Suc-LLVY-AMC (25 µM). The control proteasome activity, measured in 
unstimulated neurons, was set to 100%. The results are the average ± SEM of 3 to 8 experiments, 
performed in independent preparations. Statistical analysis was performed by ANOVA, followed by 
Dunnett's post test, comparing all the conditions with the control. All effects are statistically significant 
with ***P<0.001. B) Effect of increasing concentrations of glutamate on cell death. Hippocampal 
neurons (7 DIV) were stimulated for 20 min with 10, 20, 50 or 125 µM and further incubated in culture 
conditioned medium for 4 h. After fixation, cell death was evaluated by fluorescence microscopy with 
Hoechst 33342. The results are the average ± SEM of 9 experiments, performed in independent 
preparations. Statistical analysis was performed by ANOVA, followed by Dunnett's post test, comparing 
all the conditions with the control. All effects are statistically significant with ***P<0.001, *P<0.05 and 
**P<0.01, except where indicated as n.s. (P>0.05). 
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Proteasome activity during glutamate induced excitotoxicity 
To validate the results obtained using a fluorogenic substrate (previous section) 
which showed a downregulation of the proteasome activity under excitotoxic 
conditions, we used a GFP-based reporter strategy to monitor the rate of proteasome 
activity (Dantuma et al., 2000) under the same experimental conditions. UbG76V-GFP is 
a fusion protein comprising an ubiquitin fusion degradation (UFD)-targeted green 
fluorescent protein (GFP) that is constitutively targeted for proteasomal degradation 
under basal conditions (Dantuma et al., 2000). After transfection, hippocampal neurons 
(5 DIV) were further incubated for 48 h in cultured conditioned medium, to allow 
protein expression, before stimulation with 125 µM of glutamate for 20 min. After 4 h 
or 8 h of incubation in culture conditioned medium, we found a 2.67 (P<0.05, third 
lane) and 3.49 (P<0.01, fourth lane) fold increase in the GFP protein levels, respectively 
(Figure 16A). Similarly, the GFP protein levels increased by about 2.67 fold when the 
cells were incubated for 4 h with 1 µM of the proteasome inhibitor MG132 (Figure 
16A, P<0.05, second lane). Taken together, the results obtained with the GFP reporter 
and using the fluorogenic substrate of the proteasome indicate that excitotoxic 
stimulation of hippocampal neurons downregulates proteasome activity. 
To determine the effect of proteasome inhibition on the viability of cultured 
hippocampal neurons (7 DIV) the cells were incubated with 1 µM and 10 µM MG132 
for 5 h, and cell death was assessed by fluorescence microscopy with Hoechst33342. 
This incubation period with the proteasome inhibitor was chosen based on the results 
showing that i) excitotoxic stimulation with glutamate induces a maximal inhibition of 
the proteasome at 4-5 h after the insult (Figure 15A), and ii) cell death was observed at 
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4 h after glutamate stimulation (Figure 15B). We found that cell viability was not 
significantly affected (P>0.05) in the presence of 1 µM MG132 (Figure 16B) and, as 
expected, under the same conditions there was an accumulation of polyubiquitin 
conjugates, a common hallmark associated with proteasome inhibition, as shown by 
Western Blot analysis (Figure 16C, compare the first lane with the second). The 
accumulation of polyubiqutin conjugates was significantly higher when hippocampal 
neurons were incubated with 10 µM MG132 for 5 h (Figure 16C, compare second lane 
with the third). 
 
 
Figure 16- Effect of proteasome inhibition in hippocampal cultured neurons. A) Effect of excitotoxic 
stimulation with glutamate on the activity of the proteasome as determined with a fluorescent protein 
tagged for proteasomal degradation. UbG76V-GFP transfected hippocampal neurons were incubated with 
125 μM glutamate for 20 min and further incubated in culture conditioned medium for 4h or 8h. The 
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abundance of UbG76V-GFP was evaluated by Western blot using an anti-GFP antibody. The control 
UbG76V-GFP levels, determined in non-stimulated neurons, was set to 100%. The results are the average ± 
SEM of 3-4 independent experiments performed in different preparations. Statistical analysis was 
performed by one-way ANOVA, followed by Dunnett's test (*P<0.01, **P<0.01). B) Effect of 
proteasome inhibition on cell death. Hippocampal neurons (7 DIV) were incubated with 1 µM MG132 
during 5 h. After fixation, cell death was evaluated by fluorescence microscopy with Hoechst33342. The 
results are the average ± SEM of 8 different experiments performed in independent preparations. 
Statistical analysis was performed by unpaired Students t-test comparing the experimental condition with 
the control with n.s (P<0.05). C) Effect of proteasome inhibition on the abundance of ubiquitin-
conjugated proteins. Hippocampal neurons (7 DIV) were incubated with 1 or 10 µM MG132 during 5 h. 
The accumulation of ubiquitinated-proteins was determined by Western Blot using an antibody anti-
ubiquitin.  
Proteasome inhibition induces hippocampal cell death 
The ubiquitin-proteasome system (UPS) regulates multiple cellular functions 
(Hershko et al., 1998; Ehlers et al., 2003; Colledge et al., 2003). Also, mutations in the 
ubiquitination machinery, in proteasome substrates or even in the proteasome itself are 
associated with many neurodegenerative diseases (Ciechanover et al., 2003). Similarly, 
proteasome inhibition with synthetic compounds induces apoptosis in neurons (Qiu et 
al., 2000) by promoting the release of apoptotic factors such as cytochrome c, Smac and 
others from the mitochondria (Sun et al., 2004). Since proteasomal degradation of 
ubiquitinated substrates is the major pathway for ubiquitin recycling through associated 
deubiquitinating enzymes (Reyes-Turcu et al., 2009), its inhibition induces an 
accumulation of ubiquitinated proteins decreasing, at the same time, free ubiquitin 
levels (Patrick et al., 2003; Xu et al., 2009). 
The experimental conditions used in the previous section did not allow 
confirming that that proteasome inhibition induces cell death. This was further 
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investigated by incubating cultured hippocampal neurons with 0.05 µM, 0.1 µM or 1 
µM β-lactone, a selective and irreversible proteasome inhibitor (Lee et al., 1998), for 6 
h. At these concentrations, the proteasome chymotrypsin-like activity was decreased to 
63.6 % (P˂0.01), 28.9 % (P˂0.001) and 18.9 % (P˂0.001) of the control, respectively 
(Figure 17A). Along with proteasome inhibition, the number of polyubiquitinated-
conjugated proteins was increased, in a dose-dependent manner, as seen in the Western 
Blot analysis (Figure 17B, C), confirming the inhibition of the proteasome under the 
experimental conditions used. 
To further address the effect of proteasome inhibition on cell viability, cultured 
hippocampal neurons were incubated with 0.05 µM and 1 µM β-lactone for different 
periods of time. We found that proteasome inhibition with β-lactone can indeed induce 
hippocampal cell death. When applied at a concentration of 0.05 µM or 1 µM β-lactone 
for 12 h the proteasome inhibitor induced 22.5% (P˂0.05) and 26.9% (P˂0.01) neuronal 
death, respectively (Figure 17D). However, no difference (P>0.05) was observed using 
the same concentrations for 8 h incubation period (Figure 17D). These results suggest 
that the lack of effect of MG132 on cell survival shown in Fig. 16B is probably due to 
the short incubation period used.  
We can therefore conclude that proteasome inhibition with pharmacological 
compounds induce hippocampal cell death, with a concomitant increase in 
polyubiquitin-conjugates. Furthermore, the results show that 8 h incubation period with 
β-lactone is not enough to induce a typical apoptotic-like cell death morphology. 
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Figure 17- Proteasome inhibition induces hippocampal cell death. A-C) Effect of proteasome 
inhibition on the abundance of ubiquitin-conjugated proteins. Hippocampal neurons (7 DIV) were 
incubated with 0.05, 0.1 or 1 µM β-lactone during 6 h. A) The chymotrypsin-like activity was measured 
with the fluorogenic substrate 25 μM Suc-LLVY-AMC. The results are the average ± SEM of 3 different 
experiments performed in independent preparations. Statistical analysis was performed by one-way 
ANOVA, followed by Dunnett's test (**P<0.01, ***P<0.001). B) The accumulation of ubiquitinated-
proteins was determined by Western Blot, using an antibody anti-ubiquitin (A) and the quantification of 
the results obtained for the 75 kDa-250 kDa proteins is shown in C. The control condition, corresponding 
to neurons not exposed to the proteasome inhibitor, was set to 100%. D) Effect of proteasome inhibition 
with β-lactone on cell death. Hippocampal neurons (7 DIV) were incubated for 8h or 12h with 0.05 or 1.0 
μM β-lactone. After fixation, cell death was evaluated by fluorescence microscopy with 
Hoechst33342.The results are the average ± SEM of 3 different experiments performed in independent 
preparations Statistical analysis was performed by one-way ANOVA, followed by Dunnett's test (ns, 
P>0.04; *P<0.05; **P<0.01). 
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Oxygen and Glucose Deprivation (OGD) induces cell death in cultured 
cortical neurons 
 Oxygen and glucose deprivation is a well-known in vitro model of transient 
global ischemia (Goldberg et al., 1993). After depriving mixed cortical cultures both 
from oxygen and glucose for 50 min, overstimulation of glutamate receptors and 
consequent Ca2+ influx was described to induce ~50% of cell death (Goldberg et al., 
1993; Grabb et al., 2002). Under excitotoxic conditions the influx of Ca2+ is responsible 
for activating several intracellular proteases, including calpains and caspases (Takano et 
al., 2005). Calpain and caspase activation leads to the cleavage of several intracellular 
proteins, including α-spectrin, a 280 kDa cytoskeleton protein. While calpain activation 
is responsible for generating 150 kDa and 145 kDa spectrin fragments, activation of 
caspase-3 generate the same 150 kDa and an additional 120 kDa fragment (Wang et al., 
2000). Thus, evaluation of these truncation species is a good tool to assess 
calpain/caspase activation in neurons subjected to OGD. 
 We established a culture of cortical neurons in our laboratory as a model to 
study the mechanisms of neuronal death in in vitro ischemia. First, cell density was 
optimized (94.7x103 cells/cm2) and then the duration of OGD insult as well as the 
recovery times after the lesion. In the studies performed with 10 DIV cortical neurons, 
OGD times ranging from 40 to 135 min and recovery times between 3 to 24 h did not 
induce neuronal death (data not shown). Since neuronal loss promoted by glutamate 
increases in older cultures (Choi et al., 1987), we wondered whether OGD would have a 
stronger impact in the viability of neurons maintained in culture for a longer period. In 
fact, exposure of 14-15 DIV cortical neurons to 2 h of OGD followed by a 12 h 
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incubation period in culture conditioned medium increased LDH release by 13.8 % 
(P˂0.01) relative to the control (Figure 18A). Furthermore, at 30 min, 1 h or 2 h after 
OGD there was an increase in SBDP, which was correlated with a decrease in the 
expression of the full-length protein (Figure 18B, upper panel). Quantitative analysis of 
the results shows an increase in the SBDP by 37.1 % (P>0.05), 46.1 % (P˂0.05) and 
42.5 % (P˂0.05) when compared to control, respectively (Figure 18B, lower panel). 
 We can therefore conclude from these data that 2 h of OGD induced cortical 
neuron death, as determined 12 h after the insult. However, at 30 min after OGD it was 
possible to observe α-spectrin cleavage into 145 and 150 kDa fragments, suggesting that 
at least calpains are activated in this model. However, statistical significance was only 
observed at 1 h and 2 h after oxygen and glucose deprivation. 
 
Figure 18- OGD induces cell death in cultured cortical neurons. A) Effect of OGD in the viability of 
cultured cortical neurons. Cortical neurons (14-15 DIV) were subject to OGD for 2 h and allowed to 
recover for 12 h in cultured conditioned medium. Cell death was evaluated by the LDH assay and the 
results were normalized to the full-kill (100% cell death). The results are the average ± SEM of 7 
experiments performed in independent preparations. Statistical analysis was performed by unpaired 
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Students t-test comparing the experimental condition with the control (**P<0.01). B) Effect of OGD on 
α-spectrin cleavage. Cortical neurons (14 DIV) were subjected to OGD for 2 h and allowed to recover for 
30 min, 1h or 2h. Full-length α-spectrin and breakdown products were analyzed by Western Blotting 
(upper panel) and the percentage of SBDP was quantified by normalizing to total α-spectrin (280, 150 and 
145 kDa bands) in each condition. The results are the average ± SEM of 3 different experiments 
performed in independent preparations. Statistical analysis was performed by one-way ANOVA, followed 
by Bonferroni's test (ns, P>0.05;*P<0.05). 
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In this work we found that brief excitotoxic application of glutamate induces a 
time-dependent decrease in the proteasome chymotrypsin-like activity (Figure 15A) and 
this effect was correlated with increased cell death (Figure 15B). Although maximal 
inhibition was seen at 4 h after the insult, the activity did not fully return to basal levels. 
We further investigated the effect of the excitotoxic stimulation with glutamate on the 
activity of the proteasome using a GFP based probe that is constitutively degraded by 
the proteasome (Dantuma et al., 2000; Djakovic et al., 2009). In agreement with the 
results obtained with the fluorogenic substrate of the proteasome, excitotoxic 
stimulation of hippocampal neurons transfected with UbG76V-GFP (Dantuma et al., 
2000) increased the accumulation of the protein in the cells, showing a decrease of the 
proteolytic activity of the proteasome (Figure 16A). In a previous study this approach 
also showed that prion proteins act as an endogenous proteasome inhibitor thus 
increasing the GFP signal (Deriziotis et al., 2008).  
In a recent study from our laboratory using native gel electrophoresis it was 
shown that excitotoxic treatment with glutamate increases the 20S proteasome activity 
while the 26S proteasome activity was downregulated, suggesting that 26S proteasomes 
are dismantled rather than being inhibited by an unknown mechanism (unpublished 
data). Moreover, the UbG76V-GFP protein is constitutively directed for proteasomal 
degradation in a manner that does not require further ubiquitination, showing that its 
accumulation is promoted by 26 proteasome impairment rather than by a deficit in the 
ubiquitination machinery. These results are also correlated with the observed 
disassembly of the 26S proteasome upon transient forebrain ischemia (Asai et al., 
2002). 
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We also showed that incubation of hippocampal neurons with the proteasome 
inhibitor β-lactone induces an accumulation of ubiquitinated proteins in a concentration 
dependent manner (Figure 17C), while cell death was only observed for longer exposure 
periods (Figure 17D). These results are in agreement with others where proteasome 
inhibition was correlated with an apoptotic cell death in cultured cortical neurons (Qiu 
et al., 2000), and is associated with an increased accumulation of ubiquitinated proteins 
(Xu et al., 2009). The lack of cell death for shorter incubation periods with the 
proteasome inhibitor (Figure 17D) is also in agreement with a previous report showing 
that neuronal death is only observed for longer times of exposure (>12 h) (Ding et al., 
2006). Given the delayed effects of proteasome inhibitors on neuronal survival, the 
glutamate-induced downregulation of the proteasome activity is likely not play a major 
role in excitotoxic cell death. However, inhibition of the proteasome may play a more 
important role in the demise process when combined with other alterations in the 
proteolytic machinery of the cell, such as the increase in calpain activity that is 
characteristic of the excitotoxic and ischemic injuries.    
We established in our laboratory the appropriate experimental conditions to use 
cultured cortical neurons as a model to study the mechanisms of neuronal death after 
oxygen and glucose deprivation, an in vitro model of ischemia. Our results show that 
OGD for 2 h induced an increase around 13.8% of cell death relative to the control 
control in 14-15 DIV cortical neurons (Figure 18A). However, no cell death was 
observed in 10 DIV cell cultures using the same protocol. During cortical neuronal 
development the mRNA for the GluN1 subunit increases progressively between days 1 
and 21 in vitro. The mRNA for GluN2A only increases after 7 DIV while the mRNA 
for GluN2B increased between days 1 to 7 (Zhong et al., 1994). In contrast, expression 
of all four AMPAR subunits (GluA1-4), both mRNA and protein, are increased during 
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in vitro neuronal maturation (Orlandi et al., 2011). The lack of cell death upon 
deprivation of 10 DIV cortical neurons from oxygen and glucose may be explained by 
their immature state. Since NMDAR antagonists are neuroprotective against glutamate 
excitotoxicity (Goldberg et al., 1993), the lack of these receptors at the cell surface can 
be neuroprotective as well. Additionally, data published from Grabb and co-workers, 
shows that 50 min of OGD increases cell death by 50% when evaluated 24 h later. 
However, it is not entirely possible to compare these results with ours, due to 
differences in the OGD protocol, recovery times, cell culture density and cell culture 
components.  
We also found that α-spectrin is cleaved into 145 and 150 kDa fragments in 
cerebrocortical neurons exposed to OGD. This 145 kDa fragment is generated by 
calpain cleavage while the 150 kDa can be generated both by calpain and caspases 
(Wang et al., 1998; Wang et al., 2000), suggesting that calpains are activated with this 
OGD protocol. An additionally 120 kDa cleavage product can also be generated by 
caspase cleavage (Wang et al., 1998), but we did not observe this fragment in our WB 
analysis (data not shown). 
A major hallmark of necrosis is the LDH leakage to the extracellular medium 
occurring when cell membrane integrity is compromised (Cummings et al., 2012), and 
calpain activation is also often associated with necrotic processes (Wang et al., 2000). 
During transient forebrain ischemia protein synthesis is severely impaired, and it has 
been shown that translation activity is required for apoptosis (Paschen et al., 2003). 
However, in neuronal primary cultures early apoptotic cells are not cleared by 
phagocytosis, and often become late apoptotic cells, also known as secondary necrosis, 
when cell membrane becomes permeabilized (Poon et al., 2010). Furthermore, calpain 
activation can induce a caspase-independent apoptotic cell death mechanism by 
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inducing nuclear translocation of AIF which promotes DNA fragmentation and 
chromatin condensation (Thal et al., 2011). However, it remains to be determined 
whether neuronal death after exposure of cortical neurons to OGD, under the 
experimental conditions used in this work, occurs by necrosis or apoptosis, and further 
experiments are required to elucidate this point.  
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Previous studies showed a downregulation of the activity of the proteasome in 
experimental models of transient forebrain ischemia, which mimic stroke to a large 
extent, including the excitotoxic phenomena, ATP depletion, generation of ROS, Ca2+ 
unbalance and others. However, these studies did not elucidate the role of the 
excitotoxic injury in the downregulation of the proteasome activity. In this work we 
showed that excitotoxic stimulation of cultured hippocampal neurons induces a transient 
downregulation of the proteasome activity, which was correlated with neuronal death. 
However, inhibition of the proteasome with chemical inhibitors only showed a 
delayed effect on neuronal survival, indicating that the alteration of the proteasome after 
the excitotoxic insult, and the consequent accumulation of ubiquitinated proteins, may 
not play a major role in the demise process. In fact, whether proteasome dysfunction 
during brain ischemia is neuroprotective, i.e. if can prevent a further increase in cell 
death, or detrimental still remains to be elucidated (Meller et al., 2009). The precise 
mechanism initiated by the excitotoxic cascade that leads ultimately to proteasome 
disassembling also remains unclear. However, dissecting these mechanisms can be a 
potential therapeutical target to prevent cell death observed during stroke and other 
neurodegenerative diseases. 
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Recent results from our laboratory showed that excitotoxic stimulation with 
glutamate promotes: i) 26S proteasome disassembly into its major components, 
reducing the overall activity; ii) accumulation of ubiquitinated proteins both in the 
cytoplasm and nuclear compartments; iii) the decrease in chymotrypsin-like activity of 
the 26S proteasome was slightly prevented by cathepsin-L and caspases inhibitors and, 
iv) the overall activity of DUBs is compromised, but no effect was observed on the 
Uch-L1 activity. Given these results, it will be important to address these same 
questions in our cortical cell culture using the OGD model of in vitro ischemia. In fact, 
evaluation of proteasome activity and analysis of the accumulation of ubiquitinated 
proteins upon 2 h of OGD is ongoing work in the laboratory. Additionally, to further 
validate the method experiments should be conducted using NMDA and AMPARs 
antagonists to understand if cell death induced by OGD is dependent on the activation 
of glutamate receptors. 
Currently we are trying to identify which ubiquitinated proteins are accumulated 
in cultured cortical neurons upon proteasome disassembly. For this purpose, we are 
using tandem-repeated ubiquitin binding entities (TUBEs) (Hjerpe et al., 2009), which 
are based on UBA domains with high affinity for tetra-ubiquitin (Hjerpe et al., 2009). 
This technique allows isolating proteins with K48 and to a less extent K63 polyUb 
chains attached, and the identification of these proteins by mass-spectrometry will 
unravel novel therapeutic targets to prevent neuronal loss upon an ischemic episode. 
During the apoptotic process caspases are activated, and the controlled cleavage 
of several cytosolic proteins promotes DNA fragmentation, chromatin condensation and 
cell shrinkage (Wang et al., 2000). Additionally, it has been shown that several 
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components of the UPS can undergo selective degradation by caspases. Rpt5, Rpn2, 
Rpn10 (Adrain et al., 2004), Rpn2 (Sun et al., 2004), α2, α6 and Rpt1 (Jang et al., 2007) 
are the best characterized caspase substrates, and their cleavage contributes to 
proteasome impairment in cells committed to die. Purifying proteasomes from 
cerebrocortical neurons transduced with a Rpt6-HA tagged subunit, which is 
successfully incorporated in wild-type proteasomes (Djakovic et al., 2012), will allow 
investigating whether any of the subunits is cleaved under these conditions. There are 
several candidate proteins responsible for maintaining the 26S proteasome and, 
therefore, their degradation by caspases and/or by calpains may destabilize and 
disassemble the proteasome. Ecm29 is a protein responsible to tether the CP to the RP 
(Leggett et al., 2002), the Rpn12 subunit is responsible to join the lid and the base 
subcomplexes of the RP (Tomko et al., 2011), the Rpn6 subunit interacts with the α2 
and the Rpt6 subunits, acting as a clamp that holds together the CP and RP (Pathare et 
al., 2012), and Hsm3 is a chaperon responsible to induce a proper scaffolding of the RP 
(Barrault et al., 2012). All these proteins can be potential candidates involved in 
proteasome disassembly after OGD and in brain ischemia. Strikingly, several 
components of the RP can be themselves targeted for proteasomal degradation, 
suggesting another route for degradation in which proteasome activity can be subject of 
autoregulation, and this pathway should also be considered (Tai et al., 2010). Moreover, 
heat-shock protein 70 has been shown to protect RP from degradation upon 26S 
disassembly mediated by oxidative stress suggesting that overexpression of this protein 
during recovery periods may be beneficial by preventing proteasome impairment 
(Grune et al., 2011). 
One important question remains to be answered in this field. It is not known 
whether cell death is the cause or effect of proteasome impairment. Usp14 is a RP 
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associated DUB present substoichiometrically when compared to other resident 26S 
proteasome subunits (Tai et al., 2010), and its inhibition accelerates proteolysis in cells 
thereby ameliorating oxidative stress induced toxicity (Lee et al., 2010). The use of this 
compound can be used to counteract proteasome downregulation during ischemia by 
promoting an increase in activity in the remaining assembled proteasomes (Lee et al., 
2010). 
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